Perfusion-diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 8, 2011, Pages 876-883

  Vatter, Hartmut ^a   Güresir, Erdem ^a   Berkefeld, Joachim ^a   Beck, Jürgen ^a   Raabe, Andreas ^a   De Rochemont, Richard Du Mesnil ^a   Seifert, Volker ^a   Weidauer, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE;

ADULT; AGED; ARTICLE; BRAIN ARTERY; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; BRAIN; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; DIFFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 79960121179     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.219592     Document Type: Article

References (40)

1. Mayberg MR. Cerebral vasospasm. Neurosurg Clin NAm 1998;9:615-27. (Pubitemid 28328475)
2. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000;46:517-30. (Pubitemid 30146138)
3. Loch MR. Management of cerebral vasospasm. Neurosurg Rev 2006;29:179-93.
4. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025.
5. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009;31:151-8.
6. Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol 2010;9:504-19.
7. Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2007;60:658-67. (Pubitemid 46581089)
8. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003;98:319-25. (Pubitemid 36151027)
9. de Oliveira JG, Beck J, Ulrich C, et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 2007;30:22-30. (Pubitemid 44900231)
10. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21.
11. Beck J, Raabe A, Lanfermann H, et al. Effects of balloon angioplasty on perfusion-and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg 2006;105:220-7.
12. Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067-76. (Pubitemid 38765893)
13. Hanggi D, Turowski B, Beseoglu K, et al. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. AJNR Am J Neuroradiol 2008;29:1053-60. (Pubitemid 351954866)
14. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:819-26. (Pubitemid 38657670)
15. Oskouian RJ Jr, Martin NA, Lee JH, et al. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 2002;51:30-41.
16. Jestaedt L, Pham M, Bartsch AJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2008;62:610-17.
17. Firlik AD, Kaufmann AM, Jungreis CA, et al. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;86:830-9. (Pubitemid 27187686)
18. Beck J, Raabe A, Lanfermann H, et al. Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2004;75:1779-81. (Pubitemid 39611488)
19. Neumann-Haefelin T, Steinmetz H. Time is brain: is MRI the clock? Curr Opin Neurol 2007;20:410-16.
20. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
21. Kruetzelmann A, Siemonsen S, Gerloff C, et al. Thrombolysis targeting MRI defined tissue at risk in minor stroke. J Neurol Neurosurg Psychiatry 2009;80:1156-8.
22. Raabe A, Beck J, Keller M, et al. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2005;103:974-81. (Pubitemid 43194545)
23. Weidauer S, Lanfermann H, Raabe A, et al. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831-6. (Pubitemid 46847255)
24. Turowski B, du Mesnil DR, Beck J, et al. Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty. Neuroradiology 2005;47:134-43.
25. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729-35. (Pubitemid 37392775)
26. Condette-Auliac S, Bracard S, Anxionnat R, et al. Vasospasm after subarachnoid hemorrhage: interest in diffusion-weighted MR imaging. Stroke 2001;32:1818-24. (Pubitemid 32772213)
27. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-91.
28. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17. (Pubitemid 44871793)
29. Kohrmann M, Juttler E, Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006;5:661-7. (Pubitemid 44062409)
30. Rordorf G, Koroshetz WJ, Copen WA, et al. Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 1999;30:599-605. (Pubitemid 29115398)
31. Macdonald RL, Rosengart A, Huo D, et al. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:644-52. (Pubitemid 37159040)
32. Minhas PS, Menon DK, Smielewski P, et al. Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003;52:1017-22.
33. Kajimoto K, Moriwaki H, Yamada N, et al. Cerebral hemodynamic evaluation using perfusion-weighted magnetic resonance imaging: comparison with positron emission tomography values in chronic occlusive carotid disease. Stroke 2003;34:1662-6. (Pubitemid 36842621)
34. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-7.
35. Thijs VN, Adami A, Neumann-Haefelin T, et al. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology 2001;57:1205-11. (Pubitemid 32947377)
36. Hattingen E, Blasel S, Dettmann E, et al. Perfusion-weighted MRI to evaluate cerebral autoregulation in aneurysmal subarachnoid haemorrhage. Neuroradiology 2008;50:929-38.
37. Yundt KD, Grubb RL Jr, Diringer MN, et al. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 1998;18:419-24. (Pubitemid 28166517)
38. Rosenwasser RH, Armonda RA, Thomas JE, et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975-9.
39. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284-90. (Pubitemid 30071048)
40. Sayama CM, Liu JK, Couldwell WT. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurosurg Focus 2006;21:E12.